Randomized clinical trials

Related by string. randomized clinical trials * randomizing . randomizer . randomized : randomized controlled trial . randomized controlled trials . randomized placebo controlled / clinicals . CLINICAL . Clinicals : Phase III clinical trials . placebo controlled clinical trials . Phase III clinical / trialed . trialing . Trials : Week Premium Trial . Phase III trials . trials * *

Related by context. Frequent words. (Click for all words.) 63 immunohistochemical 62 FDG PET 62 lymphadenectomy 61 subgroup analyzes 61 noninferiority 60 histopathological 60 Observational studies 60 Computed tomography 60 chemoradiotherapy 60 sentinel node biopsy 60 prospectively defined 60 fine needle aspiration 60 ximelagatran 60 neoadjuvant therapy 59 Radiographs 59 fulvestrant 59 multivariate analyzes 59 histopathologic 59 sensitivity specificity 58 prognostic significance 58 platelet inhibition 58 olaparib 58 univariate 58 platelet reactivity 58 virologic response 58 lymph node dissection 58 therapeutic regimens 58 paclitaxel eluting stents 58 thromboprophylaxis 58 pharmacodynamic effects 58 efficacy endpoint 58 myocardial ischemia 58 lymph node metastases 57 beta blocker therapy 57 Preoperative 57 platelet function 57 mRCC 57 QTc 57 alteplase 57 antibiotic prophylaxis 57 adjuvant radiation 57 antihypertensive therapy 57 ischemic cardiomyopathy 57 inhaled nitric oxide 57 Torisel 57 MR spectroscopy 57 mucosal healing 57 nesiritide 57 cardiovascular morbidity 57 retinal thickness 57 QTc prolongation 57 nonrandomized 57 stenoses 57 sipuleucel T 57 gastrointestinal stromal tumors GIST 57 thrombolytic therapy 56 randomized controlled clinical trials 56 androgen deprivation 56 endoscopist 56 SABCS 56 lymph node involvement 56 thromboembolic events 56 coronary revascularization 56 preoperatively 56 EORTC 56 NLX P# 56 placebo controlled clinical 56 carotid artery stenting 56 histologic 56 D dimer 56 mycophenolate mofetil 56 intraoperatively 56 prespecified 56 sentinel lymph node 56 prospective multicenter 56 analgesic efficacy 56 neoadjuvant chemotherapy 56 virologic 56 surrogate endpoint 56 adjuvant therapy 56 tolvaptan 56 secretin 56 PROMACTA 56 recanalization 56 concomitant medications 56 antiplatelet therapy 56 renal toxicity 55 echocardiographic 55 infarct size 55 Retisert 55 tumor resection 55 vitro experiments 55 randomized trials 55 xenograft models 55 surrogate markers 55 HSCT 55 APOPTONE 55 mediastinal 55 Zemiva 55 liver metastases 55 prospective randomized controlled

Back to home page